{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T14:19:40Z","timestamp":1783779580700,"version":"3.55.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T00:00:00Z","timestamp":1748649600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T00:00:00Z","timestamp":1748649600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the 2019 Natural Science Foundation of Guangxi, China","award":["2019GXNSFBA245020"],"award-info":[{"award-number":["2019GXNSFBA245020"]}]},{"name":"the High-Level Talent Scientific Research Project of the Affiliated Hospital of Youjiang Medical University for Nationalities, China","award":["Y20196316"],"award-info":[{"award-number":["Y20196316"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hereditas"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Objectives<\/jats:title>\n            <jats:p>Endometriosis is a common condition among women, characterized by chronic pain and infertility, presenting significant challenges for clinicians. This study aims to identify potential druggable targets to offer new therapeutic approaches.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Method<\/jats:title>\n            <jats:p>We utilized the summary-data-based Mendelian randomization (SMR) method to investigate the causal relationships between druggable genes that encode plasma proteins and endometriosis. The data sources included the deCODE database, the UKB-PPP, and the FinnGen database. Colocalization analysis was used to identify whether candidate genes and the disease share a common causal genetic variant. Finally, we measured the protein abundance and relative mRNA expression levels of targeted druggable genes in the plasma and peripheral blood mononuclear cells (PBMCs) of endometriosis patients using ELISA and RT-qPCR.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>By integrating the results of SMR and colocalization analyses, we found that <jats:italic>EPHB4<\/jats:italic> is strongly associated with the risk of endometriosis, with higher levels of <jats:italic>EPHB4<\/jats:italic> correlating with an increased risk of the condition (P<jats:sub>FDR<\/jats:sub> &lt; 0.05, PPH4\u2009=\u20090.99). <jats:italic>RSPO3<\/jats:italic> is moderately associated, with higher levels of <jats:italic>RSPO3<\/jats:italic> correlating with an increased risk of endometriosis (P<jats:sub>FDR<\/jats:sub> &lt; 0.001, PPH4\u2009=\u20090.78). <jats:italic>CD109<\/jats:italic>, <jats:italic>SAA1<\/jats:italic>, <jats:italic>SAA2<\/jats:italic>, <jats:italic>FSHB<\/jats:italic>, and <jats:italic>SEZ6L2<\/jats:italic> are weakly associated with endometriosis, with higher levels of <jats:italic>FSHB<\/jats:italic> and <jats:italic>SEZ6L2<\/jats:italic> correlating with an increased risk of endometriosis, and higher levels of <jats:italic>CD109<\/jats:italic>, <jats:italic>SAA1<\/jats:italic>, and <jats:italic>SAA2<\/jats:italic> correlating with a decreased risk of endometriosis (P<jats:sub>FDR<\/jats:sub> &lt; 0.05, PPH4\u2009&lt;\u20090.6). ELISA and RT-qPCR analyses showed that the EPHB4 protein abundance in plasma and mRNA expression levels in PBMCs were significantly higher in the endometriosis group compared to the control group (P-value\u2009&lt;\u20090.05).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>We found that the druggable genes <jats:italic>EPHB4<\/jats:italic>, <jats:italic>CD109<\/jats:italic>, <jats:italic>SAA1<\/jats:italic>, <jats:italic>SAA2<\/jats:italic>, <jats:italic>FSHB<\/jats:italic>, and <jats:italic>SEZ6L2<\/jats:italic> may be associated with the pathogenesis of endometriosis and are potential therapeutic targets for drug treatment. However, this preliminary study is limited by sample size and population diversity, requiring further validation to confirm the reliability of these findings.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s41065-025-00457-w","type":"journal-article","created":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T12:29:39Z","timestamp":1748694579000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Identification of EPHB4 as a potential causal gene and therapeutic target for endometriosis using Mendelian randomization"],"prefix":"10.1186","volume":"162","author":[{"given":"Shaohua","family":"Ling","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delong","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lifang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siqi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liying","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,31]]},"reference":[{"issue":"10276","key":"457_CR1","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/S0140-6736(21)00389-5","volume":"397","author":"HS Taylor","year":"2021","unstructured":"Taylor HS, Kotlyar AM, Flores VA. Endometriosis is a chronic systemic disease: clinical challenges and novel innovations[J]. Lancet. 2021;397(10276):839\u201352. https:\/\/doi.org\/10.1016\/S0140-6736(21)00389-5.","journal-title":"Lancet"},{"key":"457_CR2","doi-asserted-by":"publisher","unstructured":"Horne AW, Missmer SA. Pathophysiology, diagnosis, and management of endometriosis[J]. BMJ. 2022;e070750. https:\/\/doi.org\/10.1136\/bmj-2022-070750.","DOI":"10.1136\/bmj-2022-070750"},{"issue":"2","key":"457_CR3","doi-asserted-by":"publisher","first-page":"467","DOI":"10.3390\/jcm11020467","volume":"11","author":"S Mechsner","year":"2022","unstructured":"Mechsner S. Endometriosis, an ongoing pain\u2014step-by-step treatment[J]. J Clin Med. 2022;11(2):467. https:\/\/doi.org\/10.3390\/jcm11020467.","journal-title":"J Clin Med"},{"issue":"2","key":"457_CR4","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1615\/CritRevEukaryotGeneExpr.2021037928","volume":"31","author":"P Scalia","year":"2021","unstructured":"Scalia P, Maurancy J, Giordano A, et al. Transcriptional and post-translational control mechanisms for ephb4 expression in physiology and cancer disease[J]. Crit Rev Eukaryot Gene Expr. 2021;31(2):83\u20138. https:\/\/doi.org\/10.1615\/CritRevEukaryotGeneExpr.2021037928.","journal-title":"Crit Rev Eukaryot Gene Expr"},{"key":"457_CR5","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.semcancer.2017.10.002","volume":"56","author":"Y Chen","year":"2019","unstructured":"Chen Y, Zhang H, Zhang Y. Targeting receptor tyrosine kinase ephb4 in cancer therapy[J]. Sem Cancer Biol. 2019;56:37\u201346. https:\/\/doi.org\/10.1016\/j.semcancer.2017.10.002.","journal-title":"Sem Cancer Biol"},{"issue":"14","key":"457_CR6","doi-asserted-by":"publisher","first-page":"3225","DOI":"10.1111\/bph.15044","volume":"177","author":"J Rudzitis-Auth","year":"2020","unstructured":"Rudzitis-Auth J, Fu\u00df SA, Becker V, et al. Inhibition of erythropoietin\u2010producing hepatoma receptor b4 (ephb4) signalling suppresses the vascularisation and growth of endometriotic lesions[J]. Br J Pharmacol. 2020;177(14):3225\u201339. https:\/\/doi.org\/10.1111\/bph.15044.","journal-title":"Br J Pharmacol"},{"key":"457_CR7","doi-asserted-by":"publisher","unstructured":"Emdin CA, Khera AV, Kathiresan S. Mendelian randomization[J]. JAMA. 2017;318(19): 1925. https:\/\/doi.org\/10.1001\/jama.2017.17219","DOI":"10.1001\/jama.2017.17219"},{"key":"457_CR8","doi-asserted-by":"publisher","first-page":"104934","DOI":"10.1016\/j.ebiom.2023.104934","volume":"99","author":"J Chen","year":"2024","unstructured":"Chen J, Ruan X, Sun Y, et al. Multi-omic insight into the molecular networks of mitochondrial dysfunction in the pathogenesis of inflammatory bowel disease[J]. EBioMedicine. 2024;99:104934. https:\/\/doi.org\/10.1016\/j.ebiom.2023.104934.","journal-title":"EBioMedicine"},{"issue":"12","key":"457_CR9","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1038\/s41588-021-00978-w","volume":"53","author":"E Ferkingstad","year":"2021","unstructured":"Ferkingstad E, Sulem P, Atlason BA, et al. Large-scale integration of the plasma proteome with genetics and disease[J]. Nat Genet. 2021;53(12):1712\u201321. https:\/\/doi.org\/10.1038\/s41588-021-00978-w.","journal-title":"Nat Genet"},{"issue":"7982","key":"457_CR10","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/s41586-023-06592-6","volume":"622","author":"BB Sun","year":"2023","unstructured":"Sun BB, Chiou J, Traylor M, et al. Plasma proteomic associations with genetics and health in the Uk biobank[J]. Nature. 2023;622(7982):329\u201338. https:\/\/doi.org\/10.1038\/s41586-023-06592-6.","journal-title":"Nature"},{"issue":"7944","key":"457_CR11","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/s41586-022-05473-8","volume":"613","author":"MI Kurki","year":"2023","unstructured":"Kurki MI, Karjalainen J, Palta P, et al. FinnGen provides genetic insights from a well-phenotyped isolated population[J]. Nature. 2023;613(7944):508\u201318. https:\/\/doi.org\/10.1038\/s41586-022-05473-8.","journal-title":"Nature"},{"issue":"383","key":"457_CR12","doi-asserted-by":"publisher","first-page":"eaag1166","DOI":"10.1126\/scitranslmed.aag1166","volume":"9","author":"C Finan","year":"2017","unstructured":"Finan C, Gaulton A, Kruger FA, et al. The druggable genome and support for target identification and validation in drug development[J]. Sci Transl Med. 2017;9(383):eaag1166. https:\/\/doi.org\/10.1126\/scitranslmed.aag1166.","journal-title":"Sci Transl Med"},{"issue":"5","key":"457_CR13","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/ng.3538","volume":"48","author":"Z Zhu","year":"2016","unstructured":"Zhu Z, Zhang F, Hu H, et al. Integration of summary data from Gwas and Eqtl studies predicts complex trait gene targets[J]. Nat Genet. 2016;48(5):481\u20137. https:\/\/doi.org\/10.1038\/ng.3538.","journal-title":"Nat Genet"},{"issue":"5","key":"457_CR14","doi-asserted-by":"publisher","first-page":"e1004383","DOI":"10.1371\/journal.pgen.1004383","volume":"10","author":"C Giambartolomei","year":"2014","unstructured":"Giambartolomei C, Vukcevic D, Schadt EE, et al. Bayesian test for colocalisation between pairs of genetic association studies using summary statistics[J]. PLoS Genet. 2014;10(5):e1004383. https:\/\/doi.org\/10.1371\/journal.pgen.1004383.","journal-title":"PLoS Genet"},{"issue":"11","key":"457_CR15","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1136\/jnnp-2023-331142","volume":"94","author":"W-M Su","year":"2023","unstructured":"Su W-M, Gu X-J, Dou M, et al. Systematic druggable genome-wide Mendelian randomisation identifies therapeutic targets for Alzheimer\u2019s disease[J]. J Neurol Neurosurg Psychiatry. 2023;94(11):954\u201361. https:\/\/doi.org\/10.1136\/jnnp-2023-331142.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"457_CR16","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s10194-024-01828-w","volume":"25","author":"X Sun","year":"2024","unstructured":"Sun X, Chen B, Qi Y, et al. Multi-omics Mendelian randomization integrating Gwas, Eqtl and Pqtl data revealed gstm4 as a potential drug target for migraine[J]. J Headache Pain. 2024;25(1):117. https:\/\/doi.org\/10.1186\/s10194-024-01828-w.","journal-title":"J Headache Pain"},{"issue":"D1","key":"457_CR17","doi-asserted-by":"publisher","first-page":"D1265","DOI":"10.1093\/nar\/gkad976","volume":"52","author":"C Knox","year":"2024","unstructured":"Knox C, Wilson M, Klinger CM, et al. DrugBank 6.0: the drugbank knowledgebase for 2024[J]. Nucleic Acids Res. 2024;52(D1):D1265\u201375. https:\/\/doi.org\/10.1093\/nar\/gkad976.","journal-title":"Nucleic Acids Res"},{"issue":"7","key":"457_CR18","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1093\/humrep\/det120","volume":"28","author":"DK Shah","year":"2013","unstructured":"Shah DK, Correia KF, Vitonis AF, et al. Body size and endometriosis: results from 20 years of follow-up within the nurses\u2019 health study Ii prospective cohort[J]. Hum Reprod. 2013;28(7):1783\u201392. https:\/\/doi.org\/10.1093\/humrep\/det120.","journal-title":"Hum Reprod"},{"issue":"3","key":"457_CR19","doi-asserted-by":"publisher","first-page":"227","DOI":"10.5468\/ogs.21343","volume":"65","author":"J Hong","year":"2022","unstructured":"Hong J, Yi KW. What is the link between endometriosis and adiposity?[J]. Obstet Gynecol Sci. 2022;65(3):227\u201333. https:\/\/doi.org\/10.5468\/ogs.21343.","journal-title":"Obstet Gynecol Sci"},{"issue":"6","key":"457_CR20","doi-asserted-by":"publisher","first-page":"4681","DOI":"10.1007\/s11033-020-05470-y","volume":"47","author":"E Du","year":"2020","unstructured":"Du E, Li X, He S, et al. The critical role of the interplays of ephrinb2\/ephb4 and Vegf in the induction of angiogenesis[J]. Mol Biol Rep. 2020;47(6):4681\u201390. https:\/\/doi.org\/10.1007\/s11033-020-05470-y.","journal-title":"Mol Biol Rep"},{"key":"457_CR21","doi-asserted-by":"publisher","first-page":"856316","DOI":"10.3389\/fgwh.2022.856316","volume":"3","author":"MS Chung","year":"2022","unstructured":"Chung MS, Han SJ. Endometriosis-associated angiogenesis and anti-angiogenic therapy for endometriosis[J]. Front Global Women\u2019s Health. 2022;3:856316. https:\/\/doi.org\/10.3389\/fgwh.2022.856316.","journal-title":"Front Global Women\u2019s Health"},{"issue":"5","key":"457_CR22","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.3390\/jcm9051309","volume":"9","author":"A Zubrzycka","year":"2020","unstructured":"Zubrzycka A, Zubrzycki M, Perdas E, et al. Genetic, epigenetic, and steroidogenic modulation mechanisms in endometriosis[J]. J Clin Med. 2020;9(5):1309. https:\/\/doi.org\/10.3390\/jcm9051309.","journal-title":"J Clin Med"},{"issue":"2","key":"457_CR23","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1093\/humupd\/dmy001","volume":"24","author":"MW Laschke","year":"2018","unstructured":"Laschke MW, Menger MD. Basic mechanisms of vascularization in endometriosis and their clinical implications[J]. Hum Reprod Update. 2018;24(2):207\u201324. https:\/\/doi.org\/10.1093\/humupd\/dmy001.","journal-title":"Hum Reprod Update"},{"key":"457_CR24","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.ejogrb.2016.07.500","volume":"204","author":"G Yerlikaya","year":"2016","unstructured":"Yerlikaya G, Balendran S, Pr\u00f6stling K, et al. Comprehensive study of angiogenic factors in women with endometriosis compared to women without endometriosis[J]. Eur J Obstet Gynecol Reproductive Biology. 2016;204:88\u201398. https:\/\/doi.org\/10.1016\/j.ejogrb.2016.07.500.","journal-title":"Eur J Obstet Gynecol Reproductive Biology"},{"key":"457_CR25","doi-asserted-by":"publisher","DOI":"10.1111\/aji.12134","author":"S Virani","year":"2013","unstructured":"Virani S, Edwards AK, Thomas R, et al. Blocking of stromal cell-derived factor-1 reduces neoangiogenesis in human endometriosis lesions in a mouse model[J]. Am J Reprod Immunol. 2013:n\/a-n\/a. https:\/\/doi.org\/10.1111\/aji.12134.","journal-title":"Am J Reprod Immunol"},{"issue":"9","key":"457_CR26","doi-asserted-by":"publisher","first-page":"2914","DOI":"10.1182\/blood-2006-05-023341","volume":"108","author":"O Salvucci","year":"2006","unstructured":"Salvucci O, De La Luz Sierra M, Martina JA, et al. EphB2 and ephb4 receptors forward signaling promotes sdf-1-induced endothelial cell chemotaxis and branching remodeling[J]. Blood. 2006;108(9):2914\u201322. https:\/\/doi.org\/10.1182\/blood-2006-05-023341.","journal-title":"Blood"},{"issue":"4","key":"457_CR27","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1007\/s10456-013-9366-5","volume":"16","author":"I Dimova","year":"2013","unstructured":"Dimova I, Hlushchuk R, Makanya A, et al. Inhibition of Notch signaling induces extensive intussusceptive neo-angiogenesis by recruitment of mononuclear cells[J]. Angiogenesis. 2013;16(4):921\u201337. https:\/\/doi.org\/10.1007\/s10456-013-9366-5.","journal-title":"Angiogenesis"},{"key":"457_CR28","doi-asserted-by":"publisher","unstructured":"Aslam MI, Abraham J, Mansoor A et al. PDGFR\u03b2 reverses ephb4 signaling in alveolar rhabdomyosarcoma[J]. Proceedings of the National Academy of Sciences. 2014;111(17):6383\u20136388. https:\/\/doi.org\/10.1073\/pnas.1403608111","DOI":"10.1073\/pnas.1403608111"},{"issue":"D1","key":"457_CR29","doi-asserted-by":"publisher","first-page":"D1465","DOI":"10.1093\/nar\/gkad751","volume":"52","author":"Y Zhou","year":"2024","unstructured":"Zhou Y, Zhang Y, Zhao D, et al. TTD: therapeutic target database describing target druggability information[J]. Nucleic Acids Res. 2024;52(D1):D1465\u201377. https:\/\/doi.org\/10.1093\/nar\/gkad751.","journal-title":"Nucleic Acids Res"},{"key":"457_CR30","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.ygyno.2023.06.021","volume":"176","author":"RE O\u2019Cearbhaill","year":"2023","unstructured":"O\u2019Cearbhaill RE, Miller A, Soslow RA, et al. A phase 2 study of dasatinib in recurrent clear cell carcinoma of the ovary, fallopian tube, peritoneum or endometrium: Nrg oncology\/gynecologic oncology group study 0283[J]. Gynecol Oncol. 2023;176:16\u201324. https:\/\/doi.org\/10.1016\/j.ygyno.2023.06.021.","journal-title":"Gynecol Oncol"},{"issue":"3","key":"457_CR31","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s00280-018-3646-0","volume":"82","author":"M Das","year":"2018","unstructured":"Das M, Padda SK, Frymoyer A, et al. A safety, tolerability, and Pharmacokinetic analysis of two phase i studies of multitargeted small molecule tyrosine kinase inhibitor xl647 with an intermittent and continuous dosing schedule in patients with advanced solid malignancies[J]. Cancer Chemother Pharmacol. 2018;82(3):541\u201350. https:\/\/doi.org\/10.1007\/s00280-018-3646-0.","journal-title":"Cancer Chemother Pharmacol"},{"issue":"5","key":"457_CR32","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1097\/JTO.0b013e31824c943f","volume":"7","author":"MC Pietanza","year":"2012","unstructured":"Pietanza MC, Gadgeel SM, Dowlati A, et al. Phase Ii study of the multitargeted tyrosine kinase inhibitor xl647 in patients with non-small-cell lung cancer[J]. J Thorac Oncology: Official Publication Int Association Study Lung Cancer. 2012;7(5):856\u201365. https:\/\/doi.org\/10.1097\/JTO.0b013e31824c943f.","journal-title":"J Thorac Oncology: Official Publication Int Association Study Lung Cancer"},{"issue":"4","key":"457_CR33","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1016\/j.ajpath.2010.12.037","volume":"178","author":"CM Becker","year":"2011","unstructured":"Becker CM, Beaudry P, Funakoshi T, et al. Circulating endothelial progenitor cells are up-regulated in a mouse model of endometriosis[J]. Am J Pathol. 2011;178(4):1782\u201391. https:\/\/doi.org\/10.1016\/j.ajpath.2010.12.037.","journal-title":"Am J Pathol"},{"issue":"Pt 2","key":"457_CR34","doi-asserted-by":"publisher","first-page":"131805","DOI":"10.1016\/j.ijbiomac.2024.131805","volume":"269","author":"H Zhang","year":"2024","unstructured":"Zhang H, Liu D, Xu Q-F, et al. Endothelial rspo3 mediates pulmonary endothelial regeneration by lgr4-dependent activation of \u03b2-catenin and Ilk signaling pathways after inflammatory vascular injury[J]. Int J Biol Macromol. 2024;269(Pt 2):131805. https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.131805.","journal-title":"Int J Biol Macromol"},{"issue":"7","key":"457_CR35","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.3390\/genes14071466","volume":"14","author":"J Cao","year":"2023","unstructured":"Cao J, Zhou T, Chen G, et al. Effect of exogenous hormone on r-spondin 2 (rspo2) and r-spondin 3 (rspo3) gene expression and embryo development in Chinese soft-shelled turtle (pelodiscus sinensis)[J]. Genes. 2023;14(7):1466. https:\/\/doi.org\/10.3390\/genes14071466.","journal-title":"Genes"},{"issue":"3","key":"457_CR36","doi-asserted-by":"publisher","first-page":"978","DOI":"10.3390\/biomedicines11030978","volume":"11","author":"N Monnin","year":"2023","unstructured":"Monnin N, Fattet AJ, Koscinski I. Endometriosis: update of pathophysiology, (epi) genetic and environmental involvement[J]. Biomedicines. 2023;11(3):978. https:\/\/doi.org\/10.3390\/biomedicines11030978.","journal-title":"Biomedicines"},{"key":"457_CR37","doi-asserted-by":"publisher","first-page":"1505008","DOI":"10.3389\/fimmu.2024.1505008","volume":"15","author":"A Batal","year":"2025","unstructured":"Batal A, Garousi S, Finnson KW, et al. CD109, a master regulator of inflammatory responses[J]. Front Immunol. 2025;15:1505008. https:\/\/doi.org\/10.3389\/fimmu.2024.1505008.","journal-title":"Front Immunol"},{"issue":"2","key":"457_CR38","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1111\/wrr.12023","volume":"21","author":"J Vorstenbosch","year":"2013","unstructured":"Vorstenbosch J, Gallant-Behm C, Trzeciak A, et al. Transgenic mice overexpressing CD 109 in the epidermis display decreased inflammation and granulation tissue and improved collagen architecture during wound healing[J]. Wound Repair Regeneration. 2013;21(2):235\u201346. https:\/\/doi.org\/10.1111\/wrr.12023.","journal-title":"Wound Repair Regeneration"},{"issue":"16","key":"457_CR39","doi-asserted-by":"publisher","first-page":"9033","DOI":"10.3390\/ijms22169033","volume":"22","author":"E Giacomini","year":"2021","unstructured":"Giacomini E, Minetto S, Li Piani L, et al. Genetics and inflammation in endometriosis: improving knowledge for development of new Pharmacological strategies[J]. Int J Mol Sci. 2021;22(16):9033. https:\/\/doi.org\/10.3390\/ijms22169033.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"457_CR40","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.gene.2016.02.044","volume":"583","author":"L Sun","year":"2016","unstructured":"Sun L, Ye RD. Serum amyloid a1: structure, function and gene polymorphism[J]. Gene. 2016;583(1):48\u201357. https:\/\/doi.org\/10.1016\/j.gene.2016.02.044.","journal-title":"Gene"},{"issue":"6","key":"457_CR41","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1189\/jlb.3VMR0315-080R","volume":"98","author":"RD Ye","year":"2015","unstructured":"Ye RD, Sun L. Emerging functions of serum amyloid a in inflammation[J]. J Leukoc Biol. 2015;98(6):923\u20139. https:\/\/doi.org\/10.1189\/jlb.3VMR0315-080R.","journal-title":"J Leukoc Biol"},{"issue":"1","key":"457_CR42","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1111\/j.1469-1809.2006.00299.x","volume":"71","author":"M Grigorova","year":"2007","unstructured":"Grigorova M, Rull K, Laan M. Haplotype structure of fshb, the beta-subunit gene for fertility\u2010associated follicle\u2010stimulating hormone: possible influence of balancing selection[J]. Ann Hum Genet. 2007;71(1):18\u201328. https:\/\/doi.org\/10.1111\/j.1469-1809.2006.00299.x.","journal-title":"Ann Hum Genet"},{"issue":"5","key":"457_CR43","doi-asserted-by":"publisher","first-page":"5881","DOI":"10.3892\/mmr.2017.7398","volume":"16","author":"M Matalliotakis","year":"2017","unstructured":"Matalliotakis M, Zervou MI, Matalliotaki C, et al. The role of gene polymorphisms in endometriosis[J]. Mol Med Rep. 2017;16(5):5881\u20136. https:\/\/doi.org\/10.3892\/mmr.2017.7398.","journal-title":"Mol Med Rep"},{"issue":"22","key":"457_CR44","doi-asserted-by":"publisher","first-page":"13691","DOI":"10.3390\/ijms232213691","volume":"23","author":"I Golovchenko","year":"2022","unstructured":"Golovchenko I, Aizikovich B, Golovchenko O, et al. Sex hormone candidate gene polymorphisms are associated with endometriosis[J]. Int J Mol Sci. 2022;23(22):13691. https:\/\/doi.org\/10.3390\/ijms232213691.","journal-title":"Int J Mol Sci"},{"key":"457_CR45","doi-asserted-by":"publisher","first-page":"1416978","DOI":"10.3389\/fendo.2024.1416978","volume":"15","author":"T Tao","year":"2024","unstructured":"Tao T, Mo X, Zhao L. Identifying novel potential drug targets for endometriosis via plasma proteome screening[J]. Front Endocrinol. 2024;15:1416978. https:\/\/doi.org\/10.3389\/fendo.2024.1416978.","journal-title":"Front Endocrinol"}],"container-title":["Hereditas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41065-025-00457-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41065-025-00457-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41065-025-00457-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T12:29:39Z","timestamp":1748694579000},"score":1,"resource":{"primary":{"URL":"https:\/\/hereditasjournal.biomedcentral.com\/articles\/10.1186\/s41065-025-00457-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,31]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["457"],"URL":"https:\/\/doi.org\/10.1186\/s41065-025-00457-w","relation":{},"ISSN":["1601-5223"],"issn-type":[{"value":"1601-5223","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,31]]},"assertion":[{"value":"22 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study adhered to the principles of the Helsinki Declaration. It was approved by the Ethics Committee of Youjiang Medical University for Nationalities (Approval No. YYFYY-LL-2022-61, dated 9\/9\/2022) and all participants provided written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}},{"value":"The authors declare that the research was conducted without any commercial or financial relationships that could be construed as a potential conflict of interest.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"92"}}